Bruker (BRKR) Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Bruker stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View analyst ratings for Bruker or view top-rated stocks.

3 brokers have issued twelve-month price targets for Bruker's shares. Their BRKR stock forecasts range from $60.00 to $90.00. On average, they anticipate Bruker's stock price to reach $78.33 in the next twelve months. This suggests a possible upside of 25.4% from the stock's current price.
View analysts' price targets for Bruker or view top-rated stocks among Wall Street analysts.

Bruker's stock was trading at $83.91 at the beginning of 2022. Since then, BRKR shares have decreased by 25.5% and is now trading at $62.48.
View the best growth stocks for 2022 here.

Bruker is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our earnings forecast for Bruker.

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings data on Wednesday, August, 3rd. The medical research company reported $0.45 EPS for the quarter, hitting analysts' consensus estimates of $0.45. Bruker had a trailing twelve-month return on equity of 31.36% and a net margin of 11.06%. During the same period last year, the business earned $0.44 EPS.

Bruker declared a quarterly dividend on Monday, May 16th. Stockholders of record on Wednesday, June 1st will be given a dividend of $0.05 per share on Friday, June 17th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date is Tuesday, May 31st.
View Bruker's dividend history.

Bruker(NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.32%. Bruker does not yet have a strong track record of dividend growth. The dividend payout ratio of Bruker is 11.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Bruker will have a dividend payout ratio of 7.78% next year. This indicates that Bruker will be able to sustain or increase its dividend.
View Bruker's dividend history.

Bruker updated its FY22 earnings guidance on Wednesday, August, 3rd. The company provided EPS guidance of $2.29-2.33 for the period, compared to the consensus earnings per share estimate of $2.29. The company issued revenue guidance of ~$2.48-2.53 billion, compared to the consensus revenue estimate of $2.55 billion.

126 employees have rated Bruker CEO Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among Bruker's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include TD Asset Management Inc. (1.11%), Brown Advisory Inc. (0.93%), Candriam S.C.A. (0.28%), Sector Gamma AS (0.17%), Ceredex Value Advisors LLC (0.10%) and Retirement Systems of Alabama (0.09%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BRKR stock can currently be purchased for approximately $62.48.

Bruker (NASDAQ:BRKR) has a market capitalization of $9.33 billion and generates $2.42 billion in revenue each year. The medical research company earns $277.10 million in net income (profit) each year or $1.81 on an earnings per share basis.

Bruker employs 7,765 workers across the globe.

Bruker was founded in 1960.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The official website for Bruker is www.bruker.com. The medical research company can be reached via phone at (978) 663-3660, via email at investor.relations@bruker.com, or via fax at 978-663-5585.